z-logo
open-access-imgOpen Access
P53 Arg72Pro and MDM2 SNP309 Polymorphisms Cooperate to Increase Lung Adenocarcinoma Risk in Chinese Female Non-smokers: A Case Control Study
Author(s) -
Yong Ren,
Zhihua Yin,
Yan Wan,
Peng Guan,
Wei Wu,
Xuelian Li,
Baosen Zhou
Publication year - 2013
Publication title -
asian pacific journal of cancer prevention
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.512
H-Index - 75
eISSN - 2476-762X
pISSN - 1513-7368
DOI - 10.7314/apjcp.2013.14.9.5415
Subject(s) - genotype , lung cancer , single nucleotide polymorphism , adenocarcinoma , carcinogenesis , mdm2 , medicine , oncology , snp , genotyping , cancer research , gastroenterology , biology , cancer , genetics , gene
Cell cycle deregulation is a major component of carcinogenesis. The p53 tumor suppressor gene plays an important role in regulating cell cycle arrest, and mouse double minute 2 (MDM2) is a key regulator of p53 activity and degradation. Abnormal expression of p53 and MDM2 occurs in various cancers including lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here